olodaterol
Selected indexed studies
- Tiotropium/Olodaterol: A Review in COPD. (Drugs, 2019) [PMID:31119643]
- Olodaterol. (, 2006) [PMID:29999839]
- Olodaterol for the treatment of asthma. (Expert Opin Investig Drugs, 2016) [PMID:27170011]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tiotropium/Olodaterol: A Review in COPD. (2016) pubmed
- Tiotropium/Olodaterol: A Review in COPD. (2019) pubmed
- Olodaterol. (2006) pubmed
- Olodaterol for the treatment of asthma. (2016) pubmed
- Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. (2018) pubmed
- Olodaterol for the treatment of chronic obstructive pulmonary disease. (2016) pubmed
- Olodaterol: first global approval. (2013) pubmed
- Olodaterol: a review of its use in chronic obstructive pulmonary disease. (2015) pubmed
- ▼Olodaterol--another LABA for COPD. (2015) pubmed
- The impact of olodaterol on the risk of mortality and serious adverse events: a systematic review and meta-analysis. (2017) pubmed